SI2416794T1 - Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C - Google Patents

Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C

Info

Publication number
SI2416794T1
SI2416794T1 SI200930874T SI200930874T SI2416794T1 SI 2416794 T1 SI2416794 T1 SI 2416794T1 SI 200930874 T SI200930874 T SI 200930874T SI 200930874 T SI200930874 T SI 200930874T SI 2416794 T1 SI2416794 T1 SI 2416794T1
Authority
SI
Slovenia
Prior art keywords
hepatitis
hiv
prevention
treatment
immunodeficiency virus
Prior art date
Application number
SI200930874T
Other languages
English (en)
Inventor
Kettany Sleimen El
Original Assignee
Kettany Sleimen El
El Khatib Nadia Bonja & Khoukaz Building
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kettany Sleimen El, El Khatib Nadia Bonja & Khoukaz Building filed Critical Kettany Sleimen El
Publication of SI2416794T1 publication Critical patent/SI2416794T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI200930874T 2009-04-10 2009-04-10 Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C SI2416794T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09784375.9A EP2416794B1 (fr) 2009-04-10 2009-04-10 Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c
PCT/FR2009/050678 WO2010116048A1 (fr) 2009-04-10 2009-04-10 Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang telles que les maladies causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c

Publications (1)

Publication Number Publication Date
SI2416794T1 true SI2416794T1 (sl) 2014-05-30

Family

ID=41723043

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930874T SI2416794T1 (sl) 2009-04-10 2009-04-10 Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C

Country Status (16)

Country Link
US (1) US20120076849A1 (sl)
EP (1) EP2416794B1 (sl)
JP (1) JP5472445B2 (sl)
CN (1) CN102458432B (sl)
AU (1) AU2009344046B2 (sl)
CA (1) CA2758365A1 (sl)
CY (1) CY1115326T1 (sl)
DK (1) DK2416794T3 (sl)
ES (1) ES2452482T3 (sl)
HR (1) HRP20140230T8 (sl)
PL (1) PL2416794T3 (sl)
PT (1) PT2416794E (sl)
RS (1) RS53216B (sl)
RU (1) RU2543319C2 (sl)
SI (1) SI2416794T1 (sl)
WO (1) WO2010116048A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2973249B1 (fr) * 2011-03-28 2014-02-07 Centre Nat Rech Scient Utilisation de l'epigallocatechine gallate comme agent antiviral contre les infections par le virus de l'hepatite c
KR101899122B1 (ko) * 2017-04-20 2018-09-21 주식회사 제넨셀 C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
WO2021226037A1 (en) * 2020-05-04 2021-11-11 Sulfagenix, Inc. Treatment of viral infections

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US202932A (en) * 1878-04-30 Improvement in hog-cholera compounds
FR2296426A1 (fr) * 1975-01-03 1976-07-30 Durupt Marie Helene Elixir
US4692342A (en) * 1985-11-14 1987-09-08 Nabisco Brands, Inc. Process for honey-roasting nuts
JPH0683635B2 (ja) * 1986-03-28 1994-10-26 株式会社ロツテ 抗菌作用の増強されたかりんエキスを配合した菓子類
FR2619716B1 (fr) * 1987-08-26 1991-02-08 Letourneur Bernard Medicament et produit veterinaire pour le traitement de la sterilite
FR2622800B1 (fr) * 1987-11-05 1990-03-23 Hauser Denis Procede de preparation d'un produit de lutte contre des affections virales en particulier des affections virales cutaneo-muqueuses,compositions pharmaceutiques et medicaments obtenus a partir de ce procede
JPH02270824A (ja) * 1989-04-13 1990-11-05 Snow Brand Milk Prod Co Ltd 逆転写酵素阻害剤
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
DE4490853D2 (de) * 1993-02-26 1996-06-27 Ina Levi Behandlung von (Retro)viralen Erkrankungen sowie Verfahren zur Herstellung einer pharmazeutischen Zubereitung
CN1300623A (zh) * 1999-12-20 2001-06-27 张发平 一种中成药
US6641801B1 (en) * 2000-04-03 2003-11-04 Love Lives Gargle method to reduce the duration of common cold symptoms
US6841174B2 (en) * 2000-09-20 2005-01-11 Zeyad Technologies Llc Herbal compositions and treatment methods
US20040147605A1 (en) * 2001-05-25 2004-07-29 Yoichi Onuki Drug preparations
GEP20032886B (en) * 2001-08-22 2003-02-25 Maka Burdiladze Plant Species for Treatment of Chronic Hepatite
KR20010099494A (ko) * 2001-10-09 2001-11-09 이영성, 권두한 큰등골짚신나물로부터 분리한 b형 간염바이러스 표면항원억제물질과 그 추출방법 및 용도
AU2003237060A1 (en) * 2002-06-29 2004-01-19 Biokorea Co., Ltd (e)-1-(((2e, 4e)-1-hexyl-2,4-octadecadienyl)oxy)-2-hydroxydiazine and a pharmaceutical composition for treating hepatitis
JP2004161623A (ja) * 2002-11-11 2004-06-10 Noevir Co Ltd 水性スティック状抗アクネ用組成物
DE202005007603U1 (de) * 2005-05-13 2005-08-04 HD Health Development GmbH Zusammensetzung umfassend eine Kombination aus Arganöl und Schwarzkümmelöl
FR2901699A1 (fr) * 2006-06-06 2007-12-07 Christian Maret Compositions dont les proprietes sont dues a l'association d'elements synergises, leur procede de preparation et leurs utilisations en cosmetique ou hygiene

Also Published As

Publication number Publication date
HRP20140230T1 (hr) 2014-05-09
RU2011143088A (ru) 2013-05-10
DK2416794T3 (en) 2014-03-17
US20120076849A1 (en) 2012-03-29
JP5472445B2 (ja) 2014-04-16
AU2009344046B2 (en) 2014-10-30
CN102458432A (zh) 2012-05-16
EP2416794A1 (fr) 2012-02-15
CA2758365A1 (fr) 2010-10-14
CY1115326T1 (el) 2017-01-04
PT2416794E (pt) 2014-03-17
RS53216B (en) 2014-08-29
WO2010116048A1 (fr) 2010-10-14
EP2416794B1 (fr) 2013-12-25
HRP20140230T8 (hr) 2015-12-04
CN102458432B (zh) 2015-04-22
WO2010116048A8 (fr) 2011-11-10
PL2416794T3 (pl) 2014-09-30
RU2543319C2 (ru) 2015-02-27
ES2452482T3 (es) 2014-04-01
AU2009344046A1 (en) 2011-11-10
JP2012523396A (ja) 2012-10-04

Similar Documents

Publication Publication Date Title
WO2010118367A3 (en) Antiviral pyrimidines
WO2011007230A3 (en) Lupeol-type triterpene derivatives as antivirals
IL217243A (en) Theophane 2-carboxylic acid derivatives, including pharmaceutical preparations and their uses for the preparation of flaviviridiae virus infections and hepatitis c virus infections
MX346264B (es) Compuestos antivirales.
EP2853531A3 (en) Antiviral compounds
MY170941A (en) Pyrimidine derivatives for the treatment of viral infections
HK1197026A1 (en) Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
PT3542817T (pt) Anticorpos de neutralização do vírus de imunodeficiência humana (hiv)
WO2009094191A3 (en) Methods of treating viral infections
SG179082A1 (en) Method for the preparation of an influenza virus
MX2013000242A (es) Tratamiento de enfermedades relacionadas con el virus de hepatitis c que usa hidroxicloroquina o una combinacion de hidroxicloroquina y un agente antiviral.
JO3281B1 (ar) مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي
EP2555798A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING HIV TRANSMISSIONS
HK1201262A1 (en) Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection (hcv)
HRP20140230T8 (hr) Biljna kompozicija za lijeäśenje ili prevenciju virusnih bolesti koje se prenose putem krvi, kao što su bolesti izazvane virusom humane imunodeficijencije (hiv) ili hepatitis c virusom
MX2011006516A (es) Terapia de combinacion de virus de hepatitis c.
MY171497A (en) Crystalline forms of dihydropyrimidine derivatives
GB2463584A (en) Carbohydrate-lipid constructs and their use in preventing or treating viral infection
GB201008123D0 (en) Novel compounds
PL391694A1 (pl) Modyfikowane 2',3'-dideoksynukleozydy do leczenia zakażeń szczepami ludzkiego wirusa nabytego niedoboru odporności (HIV) wykazującymi oporność wielolekową, sposób ich wytwarzania oraz środek farmaceutyczny zawierający te nukleozydy